Oncology & Immuno-Oncology Expertise

Brochure Nov 5, 2021

Immunologie, Oncologie

November 5, 2021

DOWNLOAD OUR BROCHURE

Harnessing the power of biomarkers from discovery to late-stage clinical development and companion diagnostics (CDx)

Poster: analytical validation of high-resolution ctDNA profiling with TSO500 v2.0.

Affiches

Apr 20, 2026

Scaling Liquid Biopsy Biomarker Discovery: multi-center, Analytical Validation of high resolution ctDNA Profiling Using TSO500 ctDNA v2.0 on NovaSeq X Plus

Affiches

Apr 14, 2026

Fit-for-purpose validation and inter-laboratory cross-validation of a TBNK flow cytometry assay with improved B cell monitoring capabilities

Affiches

Mar 3, 2026

Validation of an ultra-sensitive assay for biomarker testing in NSCLC patients as Clinical Trial Assay (CTA)

CellCarta has the multi-modal capabilities, scientific depth, and harmonized global footprint needed to advance even the most complex programs in precision medicine.

Oncology & Immuno-Oncology Expertise

Featured Resources

Scaling Liquid Biopsy Biomarker Discovery: multi-center, Analytical Validation of high resolution ctDNA Profiling Using TSO500 ctDNA v2.0 on NovaSeq X Plus

Fit-for-purpose validation and inter-laboratory cross-validation of a TBNK flow cytometry assay with improved B cell monitoring capabilities

Validation of an ultra-sensitive assay for biomarker testing in NSCLC patients as Clinical Trial Assay (CTA)

One global CRO for your whole therapeutic development journey